NDRG3 and Hypoglycemia: In our results describing age-dependent glucose–glycogen flux, it is notable that at 2 months of age, Ndrg3 LKO mice exhibited hypoglycemia (Figure 2A) and lower intrahepatic glucose levels (Figure 2C) without showing significant changes in fasting hepatic glycogen content compared to WT (Figure 4A).